Benefit-risk
HRT safety after the WHI headlines
A tighter explanation of what current evidence actually says about hormone therapy safety and benefit-risk framing.
Evidence summary
Current menopause guidance does not treat hormone therapy risk as one flat rule. Timing, age, route, uterus status, and personal history change the risk-benefit picture substantially.
Why women still feel confused
Many women are making a 2026 decision with a 2002 memory. The gap between the headline they remember and the nuanced evidence a clinician uses today is still enormous.
What the modern decision actually asks
The question is not 'is HRT safe' in the abstract. The useful question is 'for whom, at what age, how long since menopause, through which route, and for which symptom burden?'
What a high-quality consultation should include
You should leave with a route choice, an explanation of why that route fits your history, a discussion of uterine protection if needed, and clarity on what would make your clinician avoid hormones altogether.
Next step
Reading the evidence is useful. Matching it to your history is the real decision.
The assessment narrows symptom pattern, contraindications, and treatment preferences so a clinician can explain which option actually fits you, not just which option sounds best on a generic page.